– Meningococcal Vaccines Drive Growth and Accelerate Collaboration and Internationalization CanSino Biologics Inc. (CanSinoBIO) today disclosed its performance report for…
Browsing: BioTech
Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan…
Recognition of Avantor’s achievements in downstream processing, single-use systems, and its overall leadership as a biopharma supplier in Korea. Avantor,…
PanMediso Holdings’ international team completes core technology verification for mass production of Ac-225 PanMediso Holdings (Shenzhen) Limited, with the collaborative…
– Innovative R&D Yields Fruitful Results Once Again, Revenue Rises to RMB6.13 Billion – Adjusted Non-HKFRS Profit Attributable to the…
1H2024 Total EBITDA 27% higher at S$23.4 million vs 1H2023 of S$18.5 million; 1st Interim Dividend of 0.40 Singapore cent…
A new treatment combining tiny iron particles and nitric oxide gas shows promise in targeting oral cancer cells for destruction.…
CGFNS International, a worldwide leader in international credentials evaluation and certification to support health worker careers, has been inducted into…
Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations…
EM2AI Collaboration with AI Singapore bears fruit Improve transparency and enhance overall patient experience Mainboard listed Q & M Dental…
Exam registration for Certified Global Nurse – Rehabilitation (CGN-R) to open in July, handbook available now CGFNS International, a worldwide…
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multi-targeted therapies for chronic liver…
Group to Focus on Sustainable Growth to Continue Delivering Value to Shareholders DC Healthcare Holdings Berhad (“DC Healthcare” or the “Group”),…
HighTide Therapeutics, Inc. (HKG: 2511), a clinical stage biopharmaceutical company specializing in the development of multi-targeted therapies for chronic liver…
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from…
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with…
The research of BioMed X team EPD – Early Intervention in Psychiatric Diseases – has shed light on the molecular…
A new research team at XSeed Labs – a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models…
The planned close to 6,000 sqft facility at Royal Square in Novena is expected to commence operations by November 2024…
The 16th Annual Global CSR & ESG Summit & Awards 2024 was held on April 25 in Hanoi, Vietnam. The…